Ng George K has filed 19 insider transactions across 2 companies since January 2024.
Most recent transaction: a purchase of 1843 shares of Processa Pharmaceuticals, Inc. ($PCSA) on May 15, 2026.
Activity breakdown: 9 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 1843 | $2.97 | 12,129.0000 | 56,644,223 | 17.92% | 0.00% |
| April 15, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 1843 | $2.97 | 8,267.0000 | 56,644,223 | 28.69% | 0.00% |
| April 30, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 2034 | $2.69 | 10,301.0000 | 56,644,223 | 24.60% | 0.00% |
| March 31, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 2136 | $2.54 | 6,424.0000 | 56,644,223 | 49.81% | 0.00% |
| April 15, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 1843 | $2.97 | 8,267.0000 | 56,644,223 | 28.69% | 0.00% |
| April 15, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 1843 | $2.97 | 9,780.0000 | 56,644,223 | 23.22% | 0.00% |
| March 31, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 2136 | $2.54 | 7,937.0000 | 56,644,223 | 36.82% | 0.00% |
| Feb. 12, 2026 | TuHURA Biosciences, Inc./NV | $HURA | Ng George K | Not found | A | Options (Right to Buy) | 156240 | $0.00 | 207,515.0000 | 51,258,085 | 304.71% | 0.30% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | A | Restricted Stock Units | 256000 | $0.00 | 256,000.0000 | 5,269,240 | 9999.99% | 4.86% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | A | Stock Options (Right to Buy) | 768000 | $0.00 | 768,000.0000 | 5,269,240 | 9999.99% | 14.58% |
| July 24, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | A | Restricted Stock Units | 1822471 | $0.00 | 1,922,471.0000 | 5,269,240 | 1822.47% | 34.59% |
| Jan. 29, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | A | Warrants | 87200 | $0.00 | 87,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | A | Warrants | 43600 | $0.00 | 43,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 87200 | $0.80 | 107,200.0000 | 0 | 436.00% | 0.00% |
| Jan. 2, 2025 | TuHURA Biosciences, Inc./NV | $HURA | Ng George K | Not found | A | Options (Right to Buy) | 51275 | $0.00 | 51,275.0000 | 0 | 9999.99% | 0.00% |
| Oct. 18, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Ng George K | Not found | A | Options (Right to Buy) | 13553 | $0.00 | 13,553.0000 | 0 | 9999.99% | 0.00% |
| Oct. 18, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Ng George K | Not found | A | Options (Right to Buy) | 13553 | $0.00 | 13,553.0000 | 0 | 9999.99% | 0.00% |
| Oct. 18, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Ng George K | Not found | A | Options (Right to Buy) | 35780 | $0.00 | 35,780.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Ng George K | Chief Executive Officer | P | Common Stock | 10000 | $2.70 | 20,000.0000 | 0 | 100.00% | 0.00% |